We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 908 results
  1. The Associations Between Opioid Use Disorder and Healthcare-Related Outcomes in Vaso-occlusive Crisis

    Background

    In patients who experience frequent vaso-occlusive crises (VOC), opioid dependence may be due to a need for pain control as opposed to...

    Abdulsabur Sanni, Spencer Goble, ... Mark Linzer in Journal of General Internal Medicine
    Article 18 March 2024
  2. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease

    Pain is an hallmark of sickle-cell-related acute clinical manifestations as part of acute vaso-occlusive crisis (VOC). In SCD pain has different...

    Valeria Maria Pinto, Barbara Gianesin, ... Lucia De Franceschi in Orphanet Journal of Rare Diseases
    Article Open access 22 January 2024
  3. Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States

    Introduction

    The aim of this study was to describe the clinical complications, treatment use, healthcare resource utilization (HCRU), and costs among...

    Chuka Udeze, Kristin A. Evans, ... Biree Andemariam in Advances in Therapy
    Article Open access 18 June 2023
  4. Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States

    Background and Objective

    Gene therapies for sickle cell disease (SCD) may offer meaningful benefits for patients and society. This study evaluated the...

    William L. Herring, Meghan E. Gallagher, ... Biree Andemariam in PharmacoEconomics
    Article Open access 29 April 2024
  5. The Association between Adenotonsillectomy and Frequency of Vaso-Occlusive Crises in Patients with Sickle Cell Disease

    Sickle cell disease (SCD) typically manifests in early childhood as attacks of pain known as vaso-occlusive crises. Infection and hypoxemia have been...

    Hani Z. Marzouki, Lujain K. Abdalwassie, ... Nada J. Farsi in Indian Journal of Otolaryngology and Head & Neck Surgery
    Article 22 August 2021
  6. Intravenous Acetaminophen vs Intravenous Diclofenac Sodium in Management of Skeletal Vaso-occlusive Crisis Among Children with Homozygous Sickle Cell Disease: A Randomized Controlled Trial

    Objective

    To compare the efficacy of intravenous acetaminophen and intravenous diclofenac sodium in the management of skeletal vaso-occlusive crisis...

    Prakash Chandra Panda, Nihar Ranjan Mishra, ... Smita Kumari Panda in Indian Pediatrics
    Article 28 March 2021
  7. The impact of Hydroxyurea on the rates of Vaso–occlusive crises in patients with sickle cell disease in Saudi Arabia: a single–center study

    Background

    Vaso–occlusive crises (VOCs) are acute and common painful complication of sickle cell disease (SCD), and are the main reason behind the...

    Sahar Abdullah Alkhalifah, Miteb Alanazi, ... Yazed AlRuthia in BMC Emergency Medicine
    Article Open access 29 November 2022
  8. A systematic literature review of frequency of vaso-occlusive crises in sickle cell disease

    Background and purpose

    Sickle cell disease (SCD) is a collection of rare inherited blood disorders affecting approximately 100,000 people in the U.S....

    Ahmar U. Zaidi, Alexander K. Glaros, ... Dave Nellesen in Orphanet Journal of Rare Diseases
    Article Open access 02 November 2021
  9. The project did not come to us with a solution”: Perspectives of research teams on implementing a study about electronic health record-embedded individualized pain plans for emergency department treatment of vaso-occlusive episodes in adults with sickle cell disease

    Background

    This study aimed to capture the implementation process of the ALIGN Study, (An individualized Pain Plan with Patient and Provider Access...

    Ana A. Baumann, Jane S. Hankins, ... Allison A. King in BMC Health Services Research
    Article Open access 13 November 2023
  10. Timing matters: An analysis of the relationship between red cell transfusion timing and hospitalization outcomes in sickle cell crisis patients using the National Inpatient Sample database

    Vaso-occlusive pain crisis is a debilitating complication of sickle cell disease (SCD) and it is the most common cause of hospitalization among...

    Zubair Hassan Bodla, Mariam Hashmi, ... Sue-Wei Luu in Annals of Hematology
    Article 30 May 2023
  11. Outcomes related to intravenous fluid administration in sickle cell patients during vaso-occlusive crisis

    While fluid replacement therapy is a primary treatment modality used in vaso-occlusive crises for sickle cell disease, data is limited on its safety,...

    Daria Gaut, Jennifer Jones, ... Roswell Quinn in Annals of Hematology
    Article 04 May 2020
  12. Evaluation of the relationship between intravascular hemolysis and clinical manifestations in sickle cell disease: decreased hemopexin during vaso-occlusive crises and increased inflammation in acute chest syndrome

    The aims of this study were to determine the possible relationships between the levels of hemin, hemopexin, acid sphingomyelinase, nitrite/nitrate...

    Nazim Yildirim, Selma Unal, ... Yesim Oztas in Annals of Hematology
    Article 25 September 2021
  13. Age-related differences in risks and outcomes of 30-day readmission in adults with sickle cell disease

    Background

    Literature on 30-day readmission in adults with sickle cell disease (SCD) is limited. This study examined the overall and age-stratified...

    Ming Chen, Kenneth I. Ataga, ... James E. Bailey in Annals of Hematology
    Article 14 July 2023
  14. Evaluation of cardiac fibrosis and subclinical cardiac changes in children with sickle cell disease using magnetic resonance imaging, echocardiography, and serum galectin-3

    Background

    Myocardial fibrosis has recently been proposed as one of the contributing factors to the diverse pathogenicity of cardiomyopathy in sickle...

    Reham Wagdy, Alaa Fathy, ... Fatma Elkafrawy in Pediatric Radiology
    Article Open access 16 September 2023
  15. Jaundice in a Child with Sickle Cell Anemia: A Case Based Approach

    Sickle cell anemia (SCA) is an autosomal recessive disorder caused by a mutation in beta globin gene. Hepatobiliary system is affected in 10-40% of...

    Srinivas Srinidhi Vadlapudi, Anshu Srivastava, ... Rajanikant R. Yadav in Indian Journal of Pediatrics
    Article 09 August 2023
  16. Contrast-enhanced CT evaluation of intra-abdominal vessels in sickle cell anemia

    Background

    Sickle cell anemia (SCA) is a hereditary hematological disorder that affects millions of people worldwide. Abdominal crisis can result in...

    Article Open access 18 August 2023
  17. Death due to sickle cell crisis: a case report

    Sickle cell disease (SCD) is the most common hereditary hemoglobinopathy worldwide. It results in characteristic acute and chronic findings on...

    Teaghan Koster, Elizabeth Boyer, ... Jayantha Herath in Forensic Science, Medicine and Pathology
    Article 15 January 2024
  18. Association of plasma homocysteine level with vaso-occlusive crisis in sickle cell anemia patients of Odisha, India

    Vascular complications of sickle cell anemia (SCA) are influenced by many factors. Elevated plasma homocysteine (Hcy) is supposed to be an...

    Satyabrata Meher, Siris Patel, ... Pradeep Kumar Mohanty in Annals of Hematology
    Article 22 August 2019
  19. Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)

    REHem-AR was created in 2013. The progressive implementation of neonatal screening for haemoglobinopathies in Spanish autonomous communities where...

    José Manuel Marco Sánchez, Eduardo Jesús Bardón Cancho, ... Elena Cela in Annals of Hematology
    Article Open access 20 May 2024
  20. Apadamtase Alfa: First Approval

    Apadamtase alfa (ADAMTS13, recombinant-krhn; ADZYNMA), a human recombinant form of a disintegrin and metalloproteinase with thrombospondin motifs 13...

    Young-A. Heo in Drugs
    Article 29 February 2024
Did you find what you were looking for? Share feedback.